XML 76 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity (Tables)
12 Months Ended
Jun. 30, 2025
Shareholders’ Equity [Abstract]  
Schedule of Movement of Warrants

The movement of warrants is as follows:

 

   As of June 30, 2025 
   Valuation   Series A   Series B 
   US$   Share   Valuation   Share   Valuation 
Balance at beginning of the year  $
    
    
    
    
 
Issuance(a)   10,559,739    160,000    4,122,940    160,000    6,436,799 
Exerciset(b)   3,693,843    159,920    918,183    139,891    3,693,843 
Fair value changes(c)   (6,761,463)   
    (3,204,725)   
    (3,556,738)
Balance at end of the year  $104,433    80    32    20,109    104,401 

 

(a) On September 20, 2024, the Company issued 160,000(Pre-consolidation 4,000,000) units to public, and each unit in such offering included one Class A Ordinary Share, one Series A warrant and one Series B warrant. The Company uses the Binominal Tree pricing model to value the warrants, and the fair value allocated to the warrants at the date of issuance was $10,559,739.

 

(b)

On November 27, 2024, the holder exchanged a total of 159,920 Series A warrants (3,998,000 before the split) by signing a stock exchange agreement. The Company uses the Binominal Tree pricing model to value the warrants, and the fair value allocated to the Series A warrants at the date of exchange was $918,183.

 

In October, 2024, the Holders exercised an aggregate of 139,890(Pre-consolidation 3,497,241 ) Series B warrants through an alternative cashless exercise option. The Company uses the Binominal Tree pricing model to value the warrants, and the fair value allocated to the Series B warrants at the date of exercise was $3,693,843.

 

(c) The number of remaining unexercised Series A warrants and Series B warrants is 80 and 20,109 respectively. The fair value of these warrants as of June 30, 2025 is $104,433. The total gain from changes in the fair value of warrants for the fiscal year 2025 is $6,761,463.
Schedule of Fair Value Measurements Inputs

The following table provides quantitative information regarding Level 3 fair value measurements inputs for the Company’s warrants at their measurement dates:

 

   As of
June 30,
   As of
November 27,
   As of
October 7,
   As of
September 20,
 
   2025   2024   2024   2024 
Volatility   64.7%   64.6%   63.5%   63.0%
Stock price   1.3    0.21    0.29    0.58 
Expected life of the warrants to convert   4.2    4.81    4.95    5 
Risk free rate   3.7%   4.1%   3.9%   3.5%
Dividend yield   0%   0%   0%   0%